Katherine H Sprugel

Title: Katherine H. Sprugel: Innovator in Diabetes Treatment

Introduction

Katherine H. Sprugel is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of diabetes treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on enhancing pancreatic islet growth and regeneration.

Latest Patents

Katherine's latest patents include groundbreaking compositions aimed at stimulating pancreatic islet cell proliferation. The first patent, titled "Zinsi polypeptide composition stimulating pancreatic islet growth," provides compositions for increasing islet proliferation and β-cell mass using an insulin homolog polypeptide. This invention also outlines methods for treating diabetes by promoting islet proliferation and affecting insulin levels. The second patent, "Methods for stimulating pancreatic islet cell regeneration," similarly focuses on increasing islet proliferation and β-cell mass, offering new avenues for diabetes treatment.

Career Highlights

Katherine H. Sprugel has established herself as a key figure in her field, working at Zymogenetics, Inc. Her research has paved the way for advancements in diabetes therapies, showcasing her dedication to improving patient outcomes.

Collaborations

Throughout her career, Katherine has collaborated with notable colleagues, including Stephen R. Jaspers and Hong Ping Ren. These partnerships have further enriched her research and contributed to her success as an inventor.

Conclusion

Katherine H. Sprugel's innovative work in diabetes treatment exemplifies her commitment to advancing medical science. Her patents reflect her expertise and dedication to improving the lives of those affected by diabetes.